Sign in
Taking peopleNo phase

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Key facts

Who runs it
University Hospital, Tours
Where
France4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
10,000 people, planned
Started
9 Apr 2026
Expected to end
Apr 2036
Type of study
Observational
Record updated
6 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment
  • Obtaining non-opposition

Who cannot take part

  • Intracerebral hemorrhage secondary to another identified condition, including:; vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.); intracranial tumor; hemorrhagic transformation of a cerebral infarction; recent head trauma
  • First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting)
  • Patient under legal protection
  • Patient under guardianship or conservatorship

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.

Read full original descriptionShow less

The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.

The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
6 May 2026